4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-010501
Chief Development Officer acquired 5,720 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| See Tai Sandi Chief Development Officer | 2025-03-14 | Grant or award | +5,720 | $2.61 | $14,929 | 59,609 | D |
Loading xslF345X05/form4-04092025_090448.xml…